Posts Tagged


Aug 2020

Using AI to track down potential COVID-19 treatments with Peter Richardson

BenevolentAI’s VP of Pharmacology and Covid-19 research lead joins FierceBiotech to talk through how AI is being applied to coronavirus research.
Jul 2020

Clinical data validates BenevolentAI's AI predicted hypothesis for baricitinib as a potential treatment for COVID-19

Research published in EMBO Molecular Medicine confirms AI predictions for anti-viral and anti-cytokine signalling effects of baricitinib in critically hospitalised COVID-19 patients
Jun 2020

New tech brings new hope in our new normal w/ Joanna Shields, WeAreTechWomen

In this talk, Joanna Shields will demonstrate how human intelligence partnered with technology promises to accelerate new discoveries, new treatments, and new hope for patients.
Jun 2020

Transforming Biopharmaceutical Research with AI at The HESI Annual Meeting 2020.

Our Executive board director, Jackie Hunter, will take to the virtual stage to demonstrate how AI can be used right at the beginning of the R&D process to improve target identification and validation as well as being used to identify key pathways in disease